A recent prospective cohort study estimated the cumulative ovarian cancer risk to age 80 years as 44% (95% confidence interval [CI], 36–53%) for BRCA1 and 17% (95% CI, 11–25%) for BRCA2 mutation carriers [4]. This evidence concerns the gene BRCA1 and ovarian carcinoma.